Changing the standard of care in 2nd line recurrent cervical cancer

Description

Hear from Dr. Brian Slomovitz as he provides a debrief on the ESMO Congress 2023 LBA innovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer.

Recorded on October 27, 2023
Duration approximately 30 minutes

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

If you have questions or need assistance, contact education@igcs.org.

Faculty Information

	Brian Slomovitz, MD Director of Gynecologic Oncologic Co-Chair of the Cancer Research Committee Mount Sinai Medical Center Uterine Cancer Lead for GOG Partner USA
A specialist in clinical trial development, robotic surgery, sentinel lymph node evaluation, and immunotherapy, Dr. Brian Slomovitz is Director of gynecologic oncologic and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center in Miami Beach, Florida. He is also a Professor of Obstetrics and Gynecology at Florida International University. Dr. Slomovitz is a member of the Board of Directors at the GOG Foundation and the Uterine Cancer Lead for GOG Partners. He is also the national or global principal investigator on a number of GOG Partners, NCI, and Alliance Foundation clinical trials. He authored more than 100 peer-reviewed articles and lectured extensively. In addition, Dr. Slomovitz has been recognized as a Top Doctor by Castle Connolly Medical for the past several years. Dr. Slomovitz graduated from Rutgers University – New Jersey Medical School, and completed his residency at New York Presbyterian – Cornell Medical Center in 2002. At MD Anderson Cancer Center, he completed a fellowship in gynecologic oncology in 2006. He is board certified in both obstetrics and gynecology and gynecologic oncology.
	Floor Backes, MD Moderator Director of Clincial Research and Fellowship Director for the Division of Gynecologic Oncology The Ohio State University Wexner Medical Center James Comprehensive Cancer Center USA

Supported in part by

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

Novel combinations for treatment of recurrent cervical cancer

Drs. Bradley Monk and Wendel Naumann provide an overview of novel treatment options for recurrent cervical cancer, discuss combination therapy, and review recently completed clinical trials.

Free

Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions

An overview of the InnovaTV 204 trial data along with InnovaTV 205 data, as well as ongoing trials including InnovaTV 301.

Free

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.

Free

IGCS 2024 Cervical Master Sessions: Moving Forwards

Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.

Free

Surgical Film Library

Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations.

Free

IGCS 2024 Endometrial Cancer Master Session

Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.

Free

Uterine Cancers in the Molecular Era: Changing Trends and Implications

This 2-hour webinar will bring together international experts to explore evolving molecular insights, treatment trends, and clinical challenges in uterine cancer through lectures and a tumor board discussion.

Free

Redefining Platinum Sensitivity : Additional Treatment Considerations in a Changing Paradigm

Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.

Free

Malignant Bowel Obstruction in Gynecologic Cancers Podcast Series

This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future directions in care.

Free

Refining Molecular Classification and Personalizing Therapy in Endometrial Cancer

Presented during the IGCS and AGOI webinar Uterine Cancers in the Molecular Era: Changing Trends and Implications. Recorded on June 23, 2025.

Free